Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory mediators in allergic rhinitis.

Erwin W Gelfand1

  • 1Division of Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO, USA.

The Journal of Allergy and Clinical Immunology
|November 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene editing in allergic diseases: Identification of novel pathways and impact of deleting allergen genes.

The Journal of allergy and clinical immunology·2024
Same author

Author Correction: JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders.

Scientific reports·2023
Same author

JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders.

Scientific reports·2023
Same author

Molecular networks in atopic mothers impact the risk of infant atopy.

Allergy·2022
Same author

Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in <i>ATG9A</i>.

Autophagy·2022
Same author

Registries are shaping how we think about primary immunodeficiency diseases.

The Journal of allergy and clinical immunology·2022

Allergic rhinitis and asthma share common pathways, involving inflammatory cells like eosinophils. Understanding the timing of symptoms and medication effects can improve allergy treatment.

Area of Science:

  • Immunology
  • Allergy Research
  • Respiratory Medicine

Background:

  • Allergic rhinitis (AR) is linked to asthma, supporting the 'one airway, one disease' concept.
  • Both AR and asthma share similar immunopathology and pathophysiology.
  • Inflammatory cells, including mast cells and eosinophils, play key roles in AR and asthma.

Purpose of the Study:

  • To explore the shared immunopathology and pathophysiology of allergic rhinitis and asthma.
  • To highlight the role of inflammatory cells and mediators in allergic responses.
  • To emphasize the importance of chronobiology and circadian rhythms in allergy management.

Main Methods:

  • Review of immunologic and pathophysiologic processes in AR and asthma.
  • Identification of key inflammatory cells (mast cells, eosinophils) and mediators.

Related Experiment Videos

  • Consideration of neuropeptide involvement and diurnal symptom variations.

    • Main Results:

    • Eosinophils are central to the chronic inflammation in the late-phase allergic response.
    • Mediators released by eosinophils include cysteinyl leukotrienes and cytokines (IL-3, IL-5, GM-CSF, IL-13).
    • Neuropeptides and diurnal variations in symptoms are significant factors in AR and asthma.

    Conclusions:

    • AR and asthma share a common inflammatory basis.
    • Timing of allergy symptoms and medication administration, considering circadian rhythms, can optimize therapeutic outcomes.
    • Further research into chronobiology may enhance allergy treatments.